{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:17:02Z","timestamp":1788999422061,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry for Health, Welfare & Family Affairs, Republic of Korea","award":["A090096-0911-0000100"],"award-info":[{"award-number":["A090096-0911-0000100"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pnpbp.2012.05.011","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T14:41:14Z","timestamp":1337697674000},"page":"75-79","source":"Crossref","is-referenced-by-count":26,"title":["Symptom structure of antipsychotic-induced obsessive compulsive symptoms in schizophrenia patients"],"prefix":"10.1016","volume":"39","author":[{"given":"Joo Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyong","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meerae","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Ho","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Sue","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.05.011_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145704004456","article-title":"Obsessive\u2013compulsive symptoms with olanzapine","volume":"7","author":"Alevizos","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl.","key":"10.1016\/j.pnpbp.2012.05.011_bb0010","first-page":"18","article-title":"Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders","volume":"55","author":"Baer","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0015","first-page":"439","article-title":"Emergence of obsessive compulsive symptoms during treatment with clozapine","volume":"53","author":"Baker","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0020","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1176\/appi.ajp.2008.08020320","article-title":"Meta-analysis of the symptom structure of obsessive\u2013compulsive disorder","volume":"165","author":"Bloch","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.1700","article-title":"Exploratory factor analysis of obsessive\u2013compulsive patients and association with 5-HTTLPR polymorphism","volume":"114","author":"Cavallini","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4088\/JCP.v60n0603","article-title":"Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders","volume":"60","author":"de Haan","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2012.05.011_bb0035","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1089\/104454603322126386","article-title":"Risperidone-induced obsessive\u2013compulsive symptoms in two children","volume":"13","author":"Diler","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1819.2005.01362.x","article-title":"Obsessive\u2013compulsive symptoms in clozapine-treated schizophrenic patients","volume":"59","author":"Ertugrul","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.pnpbp.2009.05.008","article-title":"Obsessive\u2013compulsive symptom dimensions in schizophrenia patients with comorbid obsessive\u2013compulsive disorder","volume":"33","author":"Faragian","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale\u2013Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0055","first-page":"46","article-title":"Symptom dimensions of obsessive\u2013compulsive disorder and their relation to comorbid personality pathology","volume":"43","author":"Ha","year":"2004","journal-title":"J Korean Neuropsychiatr Assoc"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0060","first-page":"362","article-title":"Development of Korean version of structured clinical interview schedule for DSM-IV axis I disorder: interrater reliability","volume":"39","author":"Hahn","year":"2000","journal-title":"J Korean Neuropsychiatr Assoc"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.psychres.2005.03.003","article-title":"Obsessive\u2013compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity","volume":"135","author":"Hasler","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajmg.b.30309","article-title":"Factor analysis of obsessive\u2013compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism","volume":"141B","author":"Hasler","year":"2006","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2006.05.040","article-title":"Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD collaborative genetics study","volume":"61","author":"Hasler","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.psc.2009.08.002","article-title":"Management of schizophrenia with obsessive\u2013compulsive features","volume":"32","author":"Hwang","year":"2009","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1607-551X(09)70121-4","article-title":"Obsessive\u2013compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature","volume":"20","author":"Ke","year":"2004","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0090","first-page":"339","article-title":"Dimensional analyses of the Yale\u2013Brown obsessive\u2013compulsive scale and Yale-Brown obsessive\u2013compulsive scale checklist","volume":"15","author":"Kim","year":"2004","journal-title":"Korean J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0095","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archgenpsychiatry.2009.155","article-title":"Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive\u2013compulsive symptoms","volume":"66","author":"Kwon","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/ajp.154.7.911","article-title":"Symptoms of obsessive\u2013compulsive disorder","volume":"154","author":"Leckman","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/JCP.0b013e31815a584c","article-title":"Prevalence and clinical characteristics of obsessive\u2013compulsive symptoms associated with atypical antipsychotics","volume":"27","author":"Lim","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":"Obsessive\u2013compulsive symptoms induced by atypical antipsychotics. A review of the reported cases","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0115","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4088\/JCP.v68n0408","article-title":"De novo emergence of obsessive\u2013compulsive symptoms with atypical antipsychotics in Asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study","volume":"68","author":"Mahendran","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1176\/ajp.156.9.1409","article-title":"Use of factor-analyzed symptom of dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive\u2013compulsive disorder","volume":"156","author":"Mataix-Cols","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000064812","article-title":"Obsessive\u2013compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial","volume":"71","author":"Mataix-Cols","year":"2002","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1176\/appi.ajp.159.2.263","article-title":"Symptom stability in adult obsessive\u2013compulsive disorder: data from a naturalistic two-year follow-up study","volume":"159","author":"Mataix-Cols","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.pnpbp.2005.11.030","article-title":"Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report","volume":"30","author":"Ozer","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psychres.2007.07.010","article-title":"Further development of YBOCS dimensions in the OCD collaborative genetics study: symptoms vs. categories","volume":"160","author":"Pinto","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0145","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00023210-200418140-00004","article-title":"Obsessive\u2013compulsive disorder in schizophrenia: clinical characteristics and treatment","volume":"18","author":"Poyurovsky","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2005.06.003","article-title":"Temporal stability of symptom dimensions in adult patients with obsessive\u2013compulsive disorder","volume":"88","author":"Rufer","year":"2005","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ajmg.b.31242","article-title":"Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive\u2013compulsive symptoms","volume":"156B","author":"Ryu","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2012.05.011_bb0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.jcp.0000227809.60664.6d","article-title":"Quetiapine-induced obsessive\u2013compulsive symptoms: a series of five cases","volume":"26","author":"Stamouli","year":"2006","journal-title":"J Clin Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T21:54:47Z","timestamp":1687470887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0278584612001133"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.05.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}